aluates Reports

$ 0.0

Automative

Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-14E5608

Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Insights Forecast to 2028

BUY CHAPTERS

Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Research Report 2025

Code: QYRE-Auto-14E5608

Report

June 2025

Pages:63

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pulmonx

Olympus

Boston Scientific Corporation

Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market

The global market for Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease.

The Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Report

Report Metric	Details
Report Name	Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market
CAGR	5%
Segment by Type	Hot Steam Ablation Membrane Flap Therapy
Segment by Application	Clinics Hospitals Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pulmonx, Olympus, Boston Scientific Corporation
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market report?

Ans: The main players in the Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market are Pulmonx, Olympus, Boston Scientific Corporation

What are the Application segmentation covered in the Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market report?

Ans: The Applications covered in the Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market report are Clinics, Hospitals, Others

What are the Type segmentation covered in the Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market report?

Ans: The Types covered in the Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market report are Hot Steam Ablation, Membrane Flap Therapy

Recommended Reports

COPD and Lung Disease

Pulmonary and Respiratory Devices

Lung Disease Treatment

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Hot Steam Ablation

1.2.3 Membrane Flap Therapy

1.3 Market by Application

1.3.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Clinics

1.3.3 Hospitals

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Perspective (2020-2031)

2.2 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Growth Trends by Region

2.2.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Historic Market Size by Region (2020-2025)

2.2.3 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Forecasted Market Size by Region (2026-2031)

2.3 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Dynamics

2.3.1 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Industry Trends

2.3.2 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Drivers

2.3.3 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Challenges

2.3.4 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Players by Revenue

3.1.1 Global Top Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Players by Revenue (2020-2025)

3.1.2 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue Market Share by Players (2020-2025)

3.2 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue

3.4 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Concentration Ratio

3.4.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue in 2024

3.5 Global Key Players of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Head office and Area Served

3.6 Global Key Players of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease, Product and Application

3.7 Global Key Players of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Breakdown Data by Type

4.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Historic Market Size by Type (2020-2025)

4.2 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Forecasted Market Size by Type (2026-2031)

5 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Breakdown Data by Application

5.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Historic Market Size by Application (2020-2025)

5.2 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size (2020-2031)

6.2 North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025)

6.4 North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size (2020-2031)

7.2 Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025)

7.4 Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size (2020-2031)

8.2 Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (2020-2025)

8.4 Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size (2020-2031)

9.2 Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025)

9.4 Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size (2020-2031)

10.2 Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025)

10.4 Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pulmonx

11.1.1 Pulmonx Company Details

11.1.2 Pulmonx Business Overview

11.1.3 Pulmonx Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Introduction

11.1.4 Pulmonx Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025)

11.1.5 Pulmonx Recent Development

11.2 Olympus

11.2.1 Olympus Company Details

11.2.2 Olympus Business Overview

11.2.3 Olympus Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Introduction

11.2.4 Olympus Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025)

11.2.5 Olympus Recent Development

11.3 Boston Scientific Corporation

11.3.1 Boston Scientific Corporation Company Details

11.3.2 Boston Scientific Corporation Business Overview

11.3.3 Boston Scientific Corporation Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Introduction

11.3.4 Boston Scientific Corporation Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025)

11.3.5 Boston Scientific Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pulmonx

Olympus

Boston Scientific Corporation

List of Tables

Table 1. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Hot Steam Ablation

Table 3. Key Players of Membrane Flap Therapy

Table 4. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Region (2020-2025)

Table 8. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Region (2026-2031)

Table 10. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Trends

Table 11. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Drivers

Table 12. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Challenges

Table 13. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Restraints

Table 14. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Players (2020-2025)

Table 16. Global Top Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease as of 2024)

Table 17. Ranking of Global Top Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease, Headquarters and Area Served

Table 20. Global Key Players of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease, Product and Application

Table 21. Global Key Players of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue Market Share by Type (2020-2025)

Table 25. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue Market Share by Type (2026-2031)

Table 27. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue Market Share by Application (2020-2025)

Table 29. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue Market Share by Application (2026-2031)

Table 31. North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031) & (US$ Million)

Table 46. Pulmonx Company Details

Table 47. Pulmonx Business Overview

Table 48. Pulmonx Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Product

Table 49. Pulmonx Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025) & (US$ Million)

Table 50. Pulmonx Recent Development

Table 51. Olympus Company Details

Table 52. Olympus Business Overview

Table 53. Olympus Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Product

Table 54. Olympus Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025) & (US$ Million)

Table 55. Olympus Recent Development

Table 56. Boston Scientific Corporation Company Details

Table 57. Boston Scientific Corporation Business Overview

Table 58. Boston Scientific Corporation Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Product

Table 59. Boston Scientific Corporation Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025) & (US$ Million)

Table 60. Boston Scientific Corporation Recent Development

Table 61. Research Programs/Design for This Report

Table 62. Key Data Information from Secondary Sources

Table 63. Key Data Information from Primary Sources

Table 64. Authors List of This Report

List of Figures

Figure 1. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Picture

Figure 2. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Type: 2024 VS 2031

Figure 4. Hot Steam Ablation Features

Figure 5. Membrane Flap Therapy Features

Figure 6. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Application: 2024 VS 2031

Figure 8. Clinics Case Studies

Figure 9. Hospitals Case Studies

Figure 10. Others Case Studies

Figure 11. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Report Years Considered

Figure 12. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Region: 2024 VS 2031

Figure 15. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Players in 2024

Figure 16. Global Top Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue in 2024

Figure 18. North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Country (2020-2031)

Figure 20. United States Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Country (2020-2031)

Figure 24. Germany Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Region (2020-2031)

Figure 32. China Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Country (2020-2031)

Figure 40. Mexico Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Country (2020-2031)

Figure 44. Turkey Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Pulmonx Revenue Growth Rate in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025)

Figure 48. Olympus Revenue Growth Rate in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025)

Figure 49. Boston Scientific Corporation Revenue Growth Rate in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025)

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

Figure 52. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350